China Pharma Holdings (CPHI) Narrows Q2 Loss

China Pharma Holdings (NYSE: CPHI) reported Q2 EPS of ($0.09), versus ($0.20) reported last year. Revenue for the quarter came in at $5.7 million, versus $6.1 million reported last year.

For earnings history and earnings-related data on China Pharma Holdings (CPHI) click here.

You May Also Be Interested In

• Piper Sandler sees Google TPU sales hitting $104BN by 2028
• RBC Capital on AAR Corporation (AIR): 'Fiscal 1Q27 results could deliver upside'
• PB Fintech Limited (POLICYBZ:IN) PT Lowered to INR1,425 at Investec